Each caplet contains: Methisoprinol 500 mg.
Disease due to viral infection in respiratory tract, exanthem diseases, liver diseases, and several neurological diseases. Flu in adult and children, bronchiolitis, rhinopharyngitis, varicella, measles, herpes simplex and herpes zoster, parotitis.
Children <5 years old: 50 mg/kg body weight/day. May be increased to 100 mg/kg body weight/day, depend on severity of the disease.
Adults and children ≥5 years old: 50 mg/kg body weight/day and may be increased to 60 mg/kg body weight/day. To be given in 4-6 divided doses.
Duration of therapy: Short acute viral infection: Treatment should be continued for 1 to 2 days after symptoms subside, as advised by the physicians. This helps prevent the recurrence of the disease.
Long acute viral infection: Treatment should be continued for 1 to 2 weeks after symptoms subside, as advised by the physicians. This helps prevent the recurrence of the disease.
Administration: With or without food.
Patients with gout arthritis as this drugs may cause slight increase of uric acid in serum.
Patients receiving cardiac digitalis therapy.
Methisoprinol should not be administered in patients with bacterial infections as this drug does not have any antibacterial effect.
Methisoprinol should not be used during the first trimester of pregnancy.
The excretion of methisoprinol in breast milk is unknown.
Zoprinax caplet: The product is hygroscopic after the packaging is opened.
Caution when compounding: perform in an air-conditioned room and store in the refrigerator.
The side effects that have been consistently observed are only a temporary increase in the drug's concentration in the urine and serum uric acid levels. This increase in uric acid is due to the breakdown of inosine into uric acid, as occurs in the natural purine metabolism of inosine in the human body.
Side effects that occasionally occur and are temporary include skin rashes or itching, fatigue or malaise, and diarrhea. Rare side effects include temporary headaches, vertigo, nervousness or insomnia, constipation, and polyuria. The frequency of these side effects is not statistically significant based on the overall post-marketing surveillance data.
Clinical studies to date have not shown any drug interactions, and no food interactions are known.
J05AX05 - inosine pranobex ; Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.
Zoprinax caplet 500 mg
10 × 10's
Sign Out
